2015 annual financial data
ProQR Therapeutics 2015 Net margin
Direct answer
Net margin was -221.45%.
Operating income was -27,003,000 EUR and net income was -20,832,000 EUR.
Operating cash flow was -24,232,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,407,000 EUR
- Operating income
- -27,003,000 EUR
- Net income
- -20,832,000 EUR
- Operating cash flow
- -24,232,000 EUR